OptiBiotix Health PLC OPTI

GBX4.40 0.00 (0.00%)
View Full Chart
Find similar stocks with Morningstar Investor.
Morningstar analysts do not currently cover OPTI, but with our powerful screener, you can find stocks in the same sector, industry, or style and filter on our unbiased ratings and valuation metrics.

Trading Information

Previous Close Price
GBX4.40
Day Range
GBX4.40–4.50
52-Week Range
GBX4.40–9.00
Bid/Ask
GBX0.00 / GBX0.00
Shares Outstanding
103.30M
Market Cap
GBX454.52M
Volume/Avg
2,971 / 172,328

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
3.51
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

OptiBiotix Health PLC principal activity is that of identifying and developing microbial strains, compounds, and formulations for use in food ingredients, supplements and active compounds that can impact on human physiology, deriving potential health benefits. It is a life sciences business focused on the development of products which reduce hunger and food cravings, enhance the gut microbiome, and provide a healthy substitute for sugar. Its product portfolio includes First-generation products- SlimBiome, WellBiome; and Second-generation solutions- SweetBiotix, Microbiome Modulators. The group has one class of business. It has presence in United Kingdom, United States, India China, and Rest of world. The company generates majority of revenue from United States.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Core
Total Number of Employees
9

Valuation

Metric
OPTI
Price/Earnings (Normalized)
—
Price/Book Value
1.19
Price/Sales
3.51
Price/Cash Flow
—
Price/Earnings
OPTI

Financial Strength

Metric
OPTI
Quick Ratio
5.23
Current Ratio
6.83
Interest Coverage
—
Quick Ratio
OPTI

Profitability

Metric
OPTI
Return on Assets (Normalized)
−32.99%
Return on Equity (Normalized)
−42.47%
Return on Invested Capital (Normalized)
−36.01%
Return on Assets
OPTI

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Vertex Pharmaceuticals Inc
VRTX
LOCK|?^RnyNLOCK|^wQ%$136B
Regeneron Pharmaceuticals Inc
REGN
LOCK|TjSjZN?LOCK|Bm$!$99B
Moderna Inc
MRNA
LOCK|Z#<tK!#LOCK|Nx$87B
argenx SE ADR
ARGX
LOCK|xhm??%LOCK|>hb$61B
BeOne Medicines Ltd ADR
ONC
LOCK|DQ^@$^HLOCK|<b$48B
Royalty Pharma PLC Class A
RPRX
LOCK|<XPP#t&<LOCK|%>rFm$31B
Incyte Corp
INCY
LOCK|x&TNdTLOCK|R$$25B
Alnylam Pharmaceuticals Inc
ALNY
LOCK|Y!mD<LLOCK|rdr><$21B
BioNTech SE ADR
BNTX
LOCK|%>T&&&wLOCK|G#$$21B
Jazz Pharmaceuticals PLC
JAZZ
LOCK|nmQff<>LOCK|XjB$15B

Sponsor Center